Page last updated: 2024-08-24

remacemide and Cerebral Ischemia

remacemide has been researched along with Cerebral Ischemia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bernardi, G; Calabresi, P; Centonze, D; Costa, C; Marti, M; Picconi, B; Pisani, F; Saulle, E	1
Lees, KR; Muir, KW	1
Dyker, AG; Lees, KR	1
Schachter, SC; Tarsy, D	1

Reviews

1 review(s) available for remacemide and Cerebral Ischemia

Article	Year
Remacemide: current status and clinical applications. Expert opinion on investigational drugs, 2000, Volume: 9, Issue:4 Topics: Acetamides; Animals; Anticonvulsants; Brain Ischemia; Epilepsy; Excitatory Amino Acid Antagonists; Humans; Huntington Disease; Intraoperative Complications; Neuroprotective Agents; Parkinson Disease; Phenethylamines; Receptors, N-Methyl-D-Aspartate	2000

Trials

2 trial(s) available for remacemide and Cerebral Ischemia

Article	Year
Initial experience with remacemide hydrochloride in patients with acute ischemic stroke. Annals of the New York Academy of Sciences, 1995, Sep-15, Volume: 765 Topics: Acetamides; Adult; Aged; Aged, 80 and over; Brain Ischemia; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neuroprotective Agents	1995
Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke. Stroke, 1999, Volume: 30, Issue:9 Topics: Acetamides; Acute Disease; Adult; Aged; Aged, 80 and over; Brain Ischemia; Central Nervous System Diseases; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Neuroprotective Agents; Placebos	1999

Article

Year

Initial experience with remacemide hydrochloride in patients with acute ischemic stroke.

Annals of the New York Academy of Sciences, 1995, Sep-15, Volume: 765

Topics: Acetamides; Adult; Aged; Aged, 80 and over; Brain Ischemia; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neuroprotective Agents

1995

Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke.

Stroke, 1999, Volume: 30, Issue:9

Topics: Acetamides; Acute Disease; Adult; Aged; Aged, 80 and over; Brain Ischemia; Central Nervous System Diseases; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Neuroprotective Agents; Placebos

1999

Other Studies

1 other study(ies) available for remacemide and Cerebral Ischemia

Article	Year
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study. Experimental neurology, 2003, Volume: 182, Issue:2 Topics: Acetamides; Animals; Anticonvulsants; Brain Ischemia; Cell Hypoxia; Corpus Striatum; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Electrophysiology; Excitatory Amino Acids; Excitatory Postsynaptic Potentials; Glucose; In Vitro Techniques; Lamotrigine; Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Triazines	2003

Article

Year

Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study.

Experimental neurology, 2003, Volume: 182, Issue:2

Topics: Acetamides; Animals; Anticonvulsants; Brain Ischemia; Cell Hypoxia; Corpus Striatum; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Electrophysiology; Excitatory Amino Acids; Excitatory Postsynaptic Potentials; Glucose; In Vitro Techniques; Lamotrigine; Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Triazines

2003